Clinical Trials Browser

OTHER × tocilizumab × Gastrointestinal × Clear all

NCT02767557 2023-09-22

PACTO

Phase 2 Completed

Gastrointestinal

Unresectable Pancreatic Carcinoma

NCT04258150 2022-03-31

TRIPPLE-R

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT02997956 2017-04-25

Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular